Showing results (291-300 of 618) with videos related to
Sort By:
Pageof 62
Neuro-Oncology|February 8, 2011
A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastomaPatrick Y Wen, David Schiff, Timothy F Cloughesy, et al.Neuro-Oncology|May 13, 2017
Quantitative imaging biomarkers for risk stratification of patients with recurrent glioblastoma treated with bevacizumabPatrick Grossmann, Vivek Narayan, Ken Chang, et al.Cell Reports|October 5, 2021
Functional drug susceptibility testing using single-cell mass predicts treatment outcome in patient-derived cancer neurosphere modelsMax A Stockslager, Seth Malinowski, Mehdi Touat, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 27, 2021
IDH-mutant gliomas with additional class-defining molecular eventsJared T Ahrendsen, Matthew Torre, David M Meredith, et al.Neuro-Oncology|February 13, 2019
Recent developments and future directions in adult lower-grade gliomas: Society for Neuro-Oncology (SNO) and European Association of Neuro-Oncology (EANO) consensusDavid Schiff, Martin Van den Bent, Michael A Vogelbaum, et al.NPJ Precision Oncology|September 2, 2022
Secondary IDH1 resistance mutations and oncogenic IDH2 mutations cause acquired resistance to ivosidenib in cholangiocarcinomaJames M Cleary, Betty Rouaisnel, Antoine Daina, et al.International Journal of Radiation Oncology, Biology, Physics|May 18, 2020
Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and TemozolomideRifaquat Rahman, Lorenzo Trippa, Stephanie Alden, et al.Neuro-Oncology|May 11, 2026
Association between radiographic response and subsequent recurrence in brain metastases treated with radiation: implications for response assessment criteriaBenjamin Grobman, Nayan Lamba, Sandeep Purohit, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2016
Vaccination with Irradiated Autologous Tumor Cells Mixed with Irradiated GM-K562 Cells Stimulates Antitumor Immunity and T Lymphocyte Activation in Patients with Recurrent Malignant GliomaWilliam T Curry, Ramana Gorrepati, Matthias Piesche, et al.Journal of Neuro-Oncology|June 8, 2026
Contemporary practice patterns in IDH-mutant glioma management: a multidisciplinary multi-institutional surveyTyler A Lanman, L Nicolas Gonzalez Castro, Haley K Perlow, et al.Pageof 62